Eton Pharmaceuticals (ETON) Research & Development (2019 - 2025)
Historic Research & Development for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $1.1 million.
- Eton Pharmaceuticals' Research & Development rose 12019.8% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 114.05%. This contributed to the annual value of $3.3 million for FY2024, which is 201.69% down from last year.
- Latest data reveals that Eton Pharmaceuticals reported Research & Development of $1.1 million as of Q3 2025, which was up 12019.8% from $3.7 million recorded in Q2 2025.
- In the past 5 years, Eton Pharmaceuticals' Research & Development ranged from a high of $3.7 million in Q2 2025 and a low of -$871000.0 during Q4 2024
- Moreover, its 5-year median value for Research & Development was $944000.0 (2022), whereas its average is $1.2 million.
- Examining YoY changes over the last 5 years, Eton Pharmaceuticals' Research & Development showed a top increase of 16400.0% in 2024 and a maximum decrease of 18319.01% in 2024.
- Eton Pharmaceuticals' Research & Development (Quarter) stood at $681000.0 in 2021, then soared by 38.62% to $944000.0 in 2022, then grew by 10.91% to $1.0 million in 2023, then crashed by 183.19% to -$871000.0 in 2024, then soared by 227.67% to $1.1 million in 2025.
- Its last three reported values are $1.1 million in Q3 2025, $3.7 million for Q2 2025, and $1.2 million during Q1 2025.